Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	26
Overall Study	STARTED	Ranolazine 750 mg	27
Overall Study	STARTED	Dronedarone 225 mg	26
Overall Study	STARTED	Ranolazine 750 mg + Dronedarone 225 mg	28
Overall Study	STARTED	Ranolazine 750 mg + Dronedarone 150 mg	27
Overall Study	COMPLETED	Placebo	17
Overall Study	COMPLETED	Ranolazine 750 mg	19
Overall Study	COMPLETED	Dronedarone 225 mg	22
Overall Study	COMPLETED	Ranolazine 750 mg + Dronedarone 225 mg	20
Overall Study	COMPLETED	Ranolazine 750 mg + Dronedarone 150 mg	21
Overall Study	NOT COMPLETED	Placebo	9
Overall Study	NOT COMPLETED	Ranolazine 750 mg	8
Overall Study	NOT COMPLETED	Dronedarone 225 mg	4
Overall Study	NOT COMPLETED	Ranolazine 750 mg + Dronedarone 225 mg	8
Overall Study	NOT COMPLETED	Ranolazine 750 mg + Dronedarone 150 mg	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01522651/flow